M&A / Deals UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies pharminent May 7, 2026
Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation pharminent May 6, 2026
M&A / Deals Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline pharminent May 6, 2026
Regulatory FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight pharminent May 6, 2026
Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales pharminent May 6, 2026
M&A / Deals CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026 pharminent May 6, 2026
M&A / Deals CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine pharminent May 6, 2026
Clinical Data QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS pharminent May 5, 2026
Commercial Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings beat pharminent May 5, 2026
Market Access Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point pharminent May 5, 2026
Regulatory Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara pharminent May 5, 2026
M&A / Deals Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion pharminent May 4, 2026
Clinical Data Celcuity strengthens case for ASCO-spotlighted breast cancer drug pharminent May 4, 2026
Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026
Manufacturing PCI adds US sterile fill/finish capabilities through $1B global expansion drive pharminent May 4, 2026
Regulatory First FDA ODAC meeting without Pazdur highlights conceptual challenges with trial pharminent May 4, 2026
Clinical Data Summit shares descend as PD-1/VEGF asset misses early survival mark pharminent May 4, 2026
